Searched for
GENOMICS TESTING INDIA
Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...- Avience Biomedicals IPO: Check GMP, price band and other detailsThe grey market premium (GMP) for the issue stood at 36% ahead of the opening, implying an unofficial market price of around Rs 283 against...
- VCs turn the screws; Ex-Paisabazaar CEO’s new betHappy Friday! Investors are rewriting the rules of engagement with founders after governance blowups. This and more in today’s ETtech Morni...
- Infosys-backed 4baseCare raises Rs 128 crore, plans to take its cancer testing platform globalPrecision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...
- Claude Fable 5 & Mythos 5: Key highlights from Anthropic’s latest launchAnthropic has launched Claude Fable 5, its most capable publicly available AI model, excelling in complex tasks and benchmarks. Alongside i...
- Guardant Health to launch blood-based cancer test in India with Zydus LifesciencesGuardant Health is set to introduce a groundbreaking blood test in India for early cancer detection. This multi-cancer test, co-marketed by...
- Have machine in the loop: It is time to flip the human-in-the-loop modelTwo stories highlight how AI can empower rather than replace humans. In one, a software engineer used tools like ChatGPT and AlphaFold, alo...
- Reliance eyes Jio-style disruption in genomics with sub-Rs 1,000 testsThe energy-to-retail conglomerate is leveraging Strand Life Sciences for its entry into the emerging areas of specialised healthcare diagno...
- MedGenome, backed by Sequoia Capital, acquires Delhi-NCR based Prognosis LaboratoriesMedGenome, backed by Sequoia Capital, LeapFrog Investments, Novo Holdings, Sofina, HDFC, Emerge Ventures, Zodius Capital and International ...
- India is at the cusp of genomic revolution: Kiran Mazumdar-ShawShaw said that it was companies like Mapmygenome which are at the forefront of this 'revolution' and lauded their endeavour to expand their...
- HC asks Delhi govt to consider early re-testing of COVID-19 positive international travellersThe Delhi High Court on Tuesday said that in case there were no guidelines issued by the Centre, it expected the city government to expedit...
- Genetic tests gaining popularity in India: Who will check the gene checkers?The use of genetic tests and genomic medicine is gradually rising in India, underlining the need for a regulatory framework.
- IFC invests Rs 123 crore in genetic diagnostics firm MedGenomeMedGenome is a genomics-driven research and diagnostics company involved in decoding the genetic information contained in an individual's g...
- IFC invests USD 16.5 mn in MedGenome to increase COVID-19 testing in India"With IFC's support, we will continue to expand our services across India, bringing tests directly to the communities most affected by the ...
- New COVID-19 strain: Total 38 people in India test positiveIt said comprehensive contact tracing has been initiated for co-travellers, family contacts and others. Genome sequencing on other specimen...
- MedGenome secures $55 million funding led by LeapFrog InvestmentsMedGenome plans to use the funds raised to expand clinical genomic testing to India's tier-2 and tier-3 towns and cities, as well as toward...
- MedGenome Labs closes Series C funding round at $40 millionMedGenome will use the proceeds to expand the clinical genomic testing market by entering Tier-II and Tier-III towns and cities and “democr...
- MedGenome Labs gets Rs 192 crore in Series-C RoundThe round also saw participation from Zodius Capital, former Infosys CEO Kris Gopalakrishnan and former Cognizant CEO Lakshmi Narayanan.
- RNA sequencing test for cancer treatment launchedThe sequencing test is based on whole RNA sequencing and enhances the utility of comprehensive genomics profile manifold, bringing genomics...
- Apollo offers clinical genomics across centres in IndiaFacilitated by Sapien Biosciences – a subsidiary of Apollo Hospitals, the service will be available across all centres of Apollo Hospitals ...
Load More
